amantadine and dantrolene

amantadine has been researched along with dantrolene in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-199012 (48.00)18.7374
1990's4 (16.00)18.2507
2000's6 (24.00)29.6817
2010's3 (12.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kornhuber, J; Weller, M1
Becker, H; Bittkau, S; Przuntek, H; Schröder, J; Sczesni, B; Truong, DD; von Baumgarten, F1
Davis, JM; Janicak, PG; Sakkas, P; Wang, ZY1
Hippius, H; Spiess-Kiefer, C1
Lazarus, A3
Munitz, H; Shalev, A1
Guerrero, RM; Shifrar, KA1
Abbott, RJ; Loizou, LA1
Baxter, LR; Guzé, BH1
Ciolino, C; Rosse, R1
Neppe, VM1
Gerald, MC; Meldrum, MJ; Skau, KA1
Gómez, EA1
Marken, PA; Schneiderhan, ME1
Agrawal, M; Krishnan, P; Niranjan, S; Patel, U1
Reingardiene, D1
Childs, N; DiPasquale, MC; Eifert, B; Giacino, J; Kalmar, K; Katz, D; Long, D; Maurer, P; Mercer, W; Novak, P; Polansky, M; Whyte, J1
Caroff, SN; Keck, PE; Strawn, JR1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Glen, RC; Lowe, R; Mitchell, JB1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

8 review(s) available for amantadine and dantrolene

ArticleYear
[Pathophysiology and therapy of malignant neuroleptic syndrome].
    Der Nervenarzt, 1992, Volume: 63, Issue:11

    Topics: Amantadine; Antipsychotic Agents; Dantrolene; Dopamine; Dopamine Agents; Drug Therapy, Combination; Glutamine; Humans; Memantine; Neuroleptic Malignant Syndrome; Neurologic Examination; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate

1992
Neuroleptic malignant syndrome.
    Hospital & community psychiatry, 1989, Volume: 40, Issue:12

    Topics: Amantadine; Brain; Bromocriptine; Dantrolene; Humans; Neuroleptic Malignant Syndrome; Prognosis

1989
The neuroleptic malignant syndrome: agent and host interaction.
    Acta psychiatrica Scandinavica, 1986, Volume: 73, Issue:4

    Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Carbidopa; Child; Child, Preschool; Dantrolene; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Leukocytosis; Male; Middle Aged; Neuroleptic Malignant Syndrome

1986
Neuroleptic malignant syndrome.
    The British journal of psychiatry : the journal of mental science, 1986, Volume: 148

    Topics: Adult; Amantadine; Animals; Body Temperature; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Humans; Muscle Rigidity; Neuroleptic Malignant Syndrome; Rats

1986
Current concepts. Neuroleptic malignant syndrome.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Amantadine; Basal Ganglia Diseases; Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; Drug Interactions; Heat Exhaustion; Humans; Malignant Hyperthermia; Monoamine Oxidase Inhibitors; Neuroleptic Malignant Syndrome; Parasympatholytics

1985
[Neuroleptic malignant syndrome].
    Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:1

    Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Humans; Intensive Care Units; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Prognosis; Rhabdomyolysis

2002
Neuroleptic malignant syndrome.
    The American journal of psychiatry, 2007, Volume: 164, Issue:6

    Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Dantrolene; Diagnosis, Differential; Dopamine; Electroconvulsive Therapy; Female; Humans; Lorazepam; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Risk Factors

2007
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

17 other study(ies) available for amantadine and dantrolene

ArticleYear
[Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
    Wiener klinische Wochenschrift, 1991, Volume: 103, Issue:1

    Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Depressive Disorder; Diazepam; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Lisuride; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia

1991
Drug treatment of the neuroleptic malignant syndrome.
    Psychopharmacology bulletin, 1991, Volume: 27, Issue:3

    Topics: Amantadine; Bromocriptine; Dantrolene; Dihydroxyphenylalanine; Dopamine Agents; Humans; Neuroleptic Malignant Syndrome

1991
[Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].
    Fortschritte der Neurologie-Psychiatrie, 1986, Volume: 54, Issue:5

    Topics: Adult; Amantadine; Bromocriptine; Calcium; Cross-Sectional Studies; Dantrolene; Female; Humans; Ion Channels; Male; Malignant Hyperthermia; Muscle Contraction; Muscular Diseases; Neuroleptic Malignant Syndrome; Risk

1986
Diagnosis and treatment of neuroleptic malignant syndrome.
    Clinical pharmacy, 1988, Volume: 7, Issue:9

    Topics: Adolescent; Amantadine; Animals; Bromocriptine; Dantrolene; Electroconvulsive Therapy; Female; Humans; Neuroleptic Malignant Syndrome

1988
Therapy of neuroleptic malignant syndrome.
    Psychiatric developments, 1986,Spring, Volume: 4, Issue:1

    Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine

1986
Dopamine agonists and neuroleptic malignant syndrome.
    The American journal of psychiatry, 1985, Volume: 142, Issue:2

    Topics: Alzheimer Disease; Amantadine; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome

1985
The neuroleptic malignant syndrome. A priority system.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1984, Mar-31, Volume: 65, Issue:13

    Topics: Amantadine; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Consciousness Disorders; Dantrolene; Fever; Humans; Muscle Rigidity; Phenytoin; Syndrome

1984
Treating neuroleptic malignant syndrome.
    The American journal of psychiatry, 1984, Volume: 141, Issue:8

    Topics: Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Fever; Humans; Muscle Rigidity

1984
Biphasic amphetamine effects on skeletal muscle contractions: noncholinergic mechanisms.
    Research communications in chemical pathology and pharmacology, 1982, Volume: 35, Issue:1

    Topics: Amantadine; Animals; Dantrolene; Dextroamphetamine; In Vitro Techniques; Male; Muscle Contraction; Muscle Denervation; Norepinephrine; Procaine; Rats; Rats, Inbred Strains; Sodium-Potassium-Exchanging ATPase

1982
[Extrapyramidal reactions and neuroleptic malignant syndrome].
    Acta psiquiatrica y psicologica de America latina, 1984, Volume: 30, Issue:4

    Topics: Adult; Amantadine; Basal Ganglia Diseases; Dantrolene; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Parkinson Disease, Secondary

1984
An atypical course of neuroleptic malignant syndrome.
    Journal of clinical pharmacology, 1994, Volume: 34, Issue:4

    Topics: Amantadine; Bromocriptine; Dantrolene; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Pneumonia, Aspiration; Psychiatric Department, Hospital; Renal Insufficiency; Time Factors

1994
Neuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrhea.
    Journal of the National Medical Association, 2002, Volume: 94, Issue:4

    Topics: Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Pulmonary Edema

2002
Predictors of outcome in prolonged posttraumatic disorders of consciousness and assessment of medication effects: A multicenter study.
    Archives of physical medicine and rehabilitation, 2005, Volume: 86, Issue:3

    Topics: Adult; Aged; Amantadine; Brain Injuries; Dantrolene; Data Collection; Disability Evaluation; Dopamine Agents; Educational Status; Europe; Female; Humans; Male; Middle Aged; Muscle Relaxants, Central; Persistent Vegetative State; Predictive Value of Tests; Severity of Illness Index; Treatment Outcome; United States

2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011